Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Gyrodyne Company of America Inc (GYRO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: GYRO (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -17.81% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.19M USD | Price to earnings Ratio 45.94 | 1Y Target Price - |
Price to earnings Ratio 45.94 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.36 | 52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 |
52 Weeks Range 6.80 - 11.96 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.18 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -137.05% | Operating Margin (TTM) -121.3% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 45.94 | Forward PE - | Enterprise Value 12400998 | Price to Sales(TTM) 6.64 |
Enterprise Value 12400998 | Price to Sales(TTM) 6.64 | ||
Enterprise Value to Revenue 2.59 | Enterprise Value to EBITDA -8.07 | Shares Outstanding 2199310 | Shares Floating 662432 |
Shares Outstanding 2199310 | Shares Floating 662432 | ||
Percent Insiders 31.95 | Percent Institutions 36.97 |
Upturn AI SWOT
Gyrodyne Company of America Inc
Company Overview
History and Background
Gyrodyne Company of America Inc. was founded in 1946. Initially focused on helicopter technology, it evolved into a real estate investment trust (REIT) primarily owning and leasing medical office properties.
Core Business Areas
- Real Estate Operations: Gyrodyne owns, leases, and manages medical office properties. These properties are leased to various tenants, including physicians, medical practices, and healthcare-related companies. The company primarily focuses on income generation from these leases.
Leadership and Structure
As of the last available information, Dr. Frederick C. Filosa served as the President of the company. The company structure is relatively small, given its REIT focus. Information on the broader organizational structure or recent leadership changes is scarce in public filings.
Top Products and Market Share
Key Offerings
- Medical Office Properties: Gyrodyne leases medical office space to healthcare tenants. Information on specific market share is not readily available because REIT performance depends on geographic locations and rental rate and not market share. Competitors include other REITs specializing in medical office properties, as well as private landlords. Revenue depends heavily on occupancy rates.
Market Dynamics
Industry Overview
The medical office REIT sector is driven by factors like the aging population, increasing demand for healthcare services, and the trend towards outpatient care. The industry benefits from stable occupancy rates and long-term lease agreements.
Positioning
Gyrodyne is a small-cap REIT operating in a competitive market. Its success depends on the quality and location of its properties, as well as its ability to attract and retain tenants.
Total Addressable Market (TAM)
The TAM for medical office real estate is in the hundreds of billions of dollars, influenced by demographics and healthcare spending. Gyrodyne's market cap is minuscule compared to the overall TAM.
Upturn SWOT Analysis
Strengths
- Stable income stream from lease agreements
- Focus on medical office properties, benefiting from healthcare demand
- Long-term tenant relationships
Weaknesses
- Small market capitalization
- Limited geographic diversification
- Dependence on occupancy rates
- Lack of publicly available detailed information
Opportunities
- Acquisition of additional medical office properties
- Expansion into new geographic markets
- Renovations and upgrades to existing properties
- Capitalize on favorable healthcare demographic trends
Threats
- Economic downturns impacting tenant financial health
- Rising interest rates affecting financing costs
- Increased competition from other REITs
- Changes in healthcare regulations and reimbursement models
Competitors and Market Share
Key Competitors
- DOC
- HR
- GMRE
- OHI
Competitive Landscape
Gyrodyne is a small player compared to larger medical office REITs. Its competitive advantage would depend on specific property locations and tenant relationships.
Growth Trajectory and Initiatives
Historical Growth: Gyrodyne's growth has been limited and not a growth focused company. Public data is unavailable.
Future Projections: Without sufficient financial data, projecting future growth is not viable.
Recent Initiatives: Information on recent strategic initiatives is not publicly available.
Summary
Gyrodyne Company of America Inc. is a small-cap REIT focused on medical office properties. Its limited size and lack of public data makes it difficult to assess its performance and growth potential. It faces competition from larger REITs and is vulnerable to economic and industry-specific risks. Limited information available suggests GYRO is not a financially sound investment opportunity.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC filings (limited)
- Company website (limited)
- REIT industry reports
Disclaimers:
The information provided is based on limited publicly available data and should not be considered financial advice. Investment decisions should be made after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Gyrodyne Company of America Inc
Exchange NASDAQ | Headquaters Saint James, NY, United States | ||
IPO Launch date 1995-08-18 | President, CEO, CFO & Treasurer Mr. Gary Jay Fitlin | ||
Sector Real Estate | Industry Real Estate Services | Full time employees 6 | Website https://www.gyrodyne.com |
Full time employees 6 | Website https://www.gyrodyne.com | ||
Gyrodyne, LLC (the "Company") owns and manages a diversified portfolio of real estate properties comprising office, industrial and service-oriented properties in the New York metropolitan area. The Company owns a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York, both of which are the subject of plans to seek value-enhancing entitlements. The Company's common shares are traded on the NASDAQ Capital Market under the symbol GYRO.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.